Focus Feature: Moderna COVID-19 vaccine effective against virus variants

Two doses of Moderna COVID-19 vaccine were highly effective against all SARS-CoV-2 variants, Kaiser Permanente research published this month in BMJ showed. However, vaccine effectiveness against the delta variant moderately declined with increasing time after vaccination.

R&E News and Features

  • Heart attack patients may have delayed care over COVID-19 concerns

    A study of Kaiser Permanente Southern California members shows that rates of hospital admissions or emergency department visits for heart attacks dropped significantly after stay-at-home orders for the COVID-19 pandemic began in 2020. 

  • Image of new homepage with Virtual Research Office featured

    New Virtual Research Office enables physician research

    Kaiser Permanente Southern California has launched a new Virtual Research Office portal to make it easier for physicians to conduct clinical research that can have a direct impact on the quality of care provided to Kaiser Permanente members.

  • People with HIV are at increased risk for heart failure

    People with HIV are at higher risk of developing heart failure than people without HIV, according to a new study that is one of the largest to investigate heart failure risk in people with HIV and how that risk varies by age, gender, race, and ethnicity.

  • Higher risk of dementia for older adults living with HIV

    study reviewing 16 years of patient data found nearly double the rate of dementia among people with HIV compared with those without HIV. The research was published in the journal AIDS.